Key Takeaways
Is Weed Good for Anxiety? What the Evidence Says
Is weed good for anxiety? Controlled trials so far say no. A 2026 Lancet Psychiatry meta-analysis of 54 randomized controlled trials, with 2,477 participants, found “no significant effects on outcomes associated with anxiety” when cannabinoids were tested as a primary treatment[1].
The American Psychiatric Association reached the same conclusion in a position statement approved in December 2025: “There is insufficient evidence that cannabis is an effective treatment for any psychiatric disorder”[2]. Prevalence figures for anxiety disorders and substance use disorder, including cannabis use disorder, are on their condition pages; this article covers what research shows about cannabis as a way to manage anxiety.
Short-term effects are a separate question. Many people report feeling calmer after using cannabis, yet cannabis can also cause feelings of anxiety and paranoia[7]. How THC dose and strain labels shape those acute effects is covered in whether sativa or indica is better for anxiety; this article looks at treatment trials, long-term associations, withdrawal and quitting.
Why So Many People Use Cannabis for Anxiety
Anxiety is among the most common reasons people give for using cannabis medically. In the 2018 International Cannabis Policy Study, 27% of 27,169 respondents aged 16 to 65 in the U.S. and Canada said they had ever used cannabis for medical purposes[3].
Anxiety (52%) was the most frequently reported mental health reason for that use, ahead of depression (40%) and PTSD or trauma (17%)[3]. Self-reported medical use was more common in U.S. states with legal recreational markets (34%) than in states where cannabis was illegal (23%)[3].
These are reasons for use, not measures of benefit. The survey did not test whether symptoms improved, and its authors wrote that further research is needed to understand the safety and efficacy of this kind of medical use[3].
This pattern is often called self-medication: using a substance to relieve distress in the moment. The clinical concern is that short-term relief can sit alongside a longer cycle of tolerance and withdrawal, described below.
Anxiety as a reported mental health reason for medical cannabis use, U.S. and Canada, 2018
Anxiety was the most common mental health reason for medical cannabis use, yet randomized trials pooled in 2026 found no significant effect of cannabinoids on anxiety outcomes. That gap between use and evidence is the core of the question.
"For mental health reasons, the most common were for anxiety (52%)"
What Clinical Trials Show About Cannabis for Anxiety
The 2026 Lancet Psychiatry review pooled randomized trials published between 1980 and May 2025 that tested cannabinoids, including cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC), as the main treatment for a mental or substance use disorder[1].
Of the 54 trials, 24 (44%) had a high risk of bias, and the certainty of evidence for most outcomes was low[1]. For anxiety, the pooled results showed no significant effect[1].
Cannabinoids did show low-quality evidence of benefit for a few other conditions, including insomnia, tic disorders and cannabis use disorder itself[1]. People taking cannabinoids had higher odds of any adverse event (OR 1.75), equal to one additional person with an adverse event for every 7 treated, though serious adverse events were not more common[1].
The authors concluded that, given the scarcity of evidence, routine use of cannabinoids to treat mental disorders “is currently rarely justified”[1].
No cannabis product is FDA-approved to treat anxiety. The FDA has approved one cannabis-derived drug, Epidiolex (purified CBD), for seizures associated with Lennox-Gastaut or Dravet syndrome, and three synthetic cannabis-related drugs, Marinol, Syndros and Cesamet, for uses such as chemotherapy-related nausea[8]. The agency states that it has not approved any other cannabis, cannabis-derived or CBD products on the market[8].
Cannabis and Anxiety: What Different Study Types Found
| Study | Design | Finding on anxiety | Year |
|---|---|---|---|
| Wilson et al., Lancet Psychiatry | Meta-analysis, 54 RCTs | No significant effect on anxiety outcomes | 2026 |
| American Psychiatric Association | Position statement | Insufficient evidence cannabis treats any psychiatric disorder | 2025 |
| Leung et al., Psychopharmacology | Survey, 27,169 respondents (2018 data) | Anxiety (52%) was the top mental health reason for medical use | 2022 |
| Bahji et al., JAMA Network Open | Meta-analysis, 47 studies | 47% withdrawal syndrome; anxiety is a core symptom | 2020 |
| Hall et al., Colorado ED data | 4.69 million ED visits (2012-2014) | Anxiety diagnosis 3.82% vs 0.97% without cannabis codes | 2018 |
| Hser et al., J Subst Abuse Treat | Secondary analysis, 302 adults | Reduced use linked to improved anxiety | 2017 |
| Kedzior and Laeber, BMC Psychiatry | Meta-analysis, 31 studies | OR 1.24 with cannabis use; OR 1.68 with cannabis use disorder | 2014 |
1OR = odds ratio; ED = emergency department; RCT = randomized controlled trial.
2Only the Wilson et al. meta-analysis pools randomized trials; the other studies are observational and show associations, not causes.
Sources
- •Wilson et al., 2026
- •APA, 2025
- •Leung et al., 2022
- •Bahji et al., 2020
- •Hall et al., 2018
- •Hser et al., 2017
- •Kedzior and Laeber, 2014
Can Weed Make Anxiety Worse?
CDC states that cannabis use “can cause disorientation and sometimes unpleasant thoughts or feelings of anxiety and paranoia”[7]. CDC also lists social anxiety among the conditions associated with cannabis use; data on social anxiety disorder are on its condition page[7].
Population studies find a small, consistent link. A 2014 meta-analysis of 31 studies, drawn from about 112,000 people in 10 countries, found anxiety was associated with cannabis use (odds ratio 1.24, 15 studies) and more strongly with cannabis use disorder (odds ratio 1.68, 13 studies)[4].
Direction is harder to pin down. In 5 studies adjusted for confounders, cannabis use at baseline was associated with anxiety at follow-up (odds ratio 1.28), while only one study had examined whether anxiety comes first[4]. The review's literature search ended in March 2013, so it does not reflect more recent cohorts[4].
Hospital records show a similar pattern. In Colorado emergency departments from 2012 to 2014, anxiety disorders were the primary diagnosis in 3.82% of visits with cannabis-related codes, compared with 0.97% of visits without them, a prevalence ratio of 3.94[9]. The study counted visits rather than individual patients, and coded records cannot show that cannabis caused the anxiety[9].
Cannabis withdrawal syndrome
A set of symptoms that develops after heavy, prolonged cannabis use is reduced or stopped. DSM-5 criteria require at least 3 of 7 symptoms within 7 days of reduced use: irritability or anger, nervousness or anxiety, sleep disturbance, appetite or weight change, restlessness, depressed mood, and physical symptoms such as headache or sweating[5].
Related Terms
Source: DSM-5 criteria as summarized in Bahji et al., JAMA Network Open, 2020
Rebound Anxiety and Cannabis Withdrawal
Anxiety is one of the defining symptoms of cannabis withdrawal. A 2020 JAMA Network Open meta-analysis of 47 studies and 23,518 participants estimated that 47% of people with regular or dependent cannabis use experience withdrawal syndrome[5].
The rate was 17% in population-based samples, 54% in outpatient samples and 87% in inpatient samples, and daily cannabis use was associated with a higher prevalence[5].
The review describes withdrawal symptoms as transient and notes they “could be ameliorated by readministration of cannabis”[5]. That loop can look like anxiety relief: nervousness that builds between uses eases when cannabis is used again.
Regular use also carries a risk of addiction. CDC estimates that approximately 3 in 10 people who use cannabis have cannabis use disorder, with greater risk for those who start young and use more often[10]. Risk factors are covered in substance use disorder risk factors, and data on anxiety and addiction occurring together are on the co-occurring disorders page.
Does Quitting Weed Help Anxiety?
The evidence here comes mainly from treatment studies rather than trials built to answer the question. One secondary analysis followed 302 adults aged 18 to 50 through a 12-week medication trial for cannabis use disorder[6].
Participants whose cannabis use declined (152 people) showed significantly greater improvement in anxiety, depression and sleep quality than those whose use increased (150 people), after adjusting for demographics, treatment group, and tobacco and alcohol use[6]. Quality of life did not differ between the groups[6].
The design shows an association over time, not proof that cutting back caused the improvement. The authors concluded that clinicians treating co-occurring cannabis use and anxiety should “attend to cannabis use reduction as a component of treatment”[6].
Because withdrawal can include anxiety, symptoms may rise before they ease; the JAMA Network Open review describes withdrawal symptoms as transient[5]. Treatments with established trial evidence for anxiety disorders are reviewed in therapy for anxiety and anxiety medication.
What the Research Still Cannot Answer
The 54 trials in the 2026 review included 2,477 participants in total, and the review found no randomized trial evidence at all for cannabinoids as a primary treatment for depression, a condition that often occurs with anxiety[1].
The observational studies that dominate this field cannot separate cause from effect, and much of the survey data relies on self-report. The APA has called for more research on the benefits and harms of cannabis derivatives and for cannabis products to have the same oversight as other FDA-approved drugs[2].
For now, the evidence on weed and anxiety rests on self-reported relief, a small set of trials showing no significant benefit, and observational links between heavier use and more anxiety. The same gap between reported relief and trial results appears in research on cannabis and ADHD.
Frequently Asked Questions
Sources & References
- Wilson J, Dobson O, Langcake A, et al. The efficacy and safety of cannabinoids for the treatment of mental disorders and substance use disorders: a systematic review and meta-analysis. The Lancet Psychiatry. Published 2026. Accessed October 2026. https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(26)00015-5/fulltext [Link]
- American Psychiatric Association. Position Statement in Opposition to Cannabis as Medicine for Psychiatric Disorders. American Psychiatric Association. Published 2025. Accessed October 2026. https://www.psychiatry.org/getattachment/12aa44f8-016e-4f8c-8b92-d3fb11a7155f/Position-Cannabis-as-Medicine.pdf [Link]
- Leung J, Chan G, Stjepanović D, et al. Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada. Psychopharmacology. Published 2022. Accessed October 2026. https://link.springer.com/article/10.1007/s00213-021-06047-8 [Link]
- Kedzior KK, Laeber LT. A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population: a meta-analysis of 31 studies. BMC Psychiatry. Published 2014. Accessed October 2026. https://bmcpsychiatry.biomedcentral.com/articles/10.1186/1471-244X-14-136 [Link]
- Bahji A, Stephenson C, Tyo R, Hawken ER, Seitz DP. Prevalence of cannabis withdrawal symptoms among people with regular or dependent use of cannabinoids: a systematic review and meta-analysis. JAMA Network Open. Published 2020. Accessed October 2026. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2764234 [Link]
- Hser YI, Mooney LJ, Huang D, et al. Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life. Journal of Substance Abuse Treatment. Published 2017. Accessed October 2026. https://doi.org/10.1016/j.jsat.2017.07.012 [Link]
- Centers for Disease Control and Prevention. Cannabis and Mental Health. Centers for Disease Control and Prevention. Published 2024. Accessed October 2026. https://www.cdc.gov/cannabis/health-effects/mental-health.html [Link]
- U.S. Food and Drug Administration. FDA and Cannabis: Research and Drug Approval Process. U.S. Food and Drug Administration. Published 2023. Accessed October 2026. https://www.fda.gov/news-events/public-health-focus/fda-and-cannabis-research-and-drug-approval-process [Link]
- Hall KE, Monte AA, Chang T, et al. Mental health-related emergency department visits associated with cannabis in Colorado. CDC Stacks. Published 2018. Accessed October 2026. https://stacks.cdc.gov/view/cdc/230482/cdc_230482_DS1.pdf [Link]
- Centers for Disease Control and Prevention. Understanding Your Risk for Cannabis Use Disorder. Centers for Disease Control and Prevention. Published 2024. Accessed October 2026. https://www.cdc.gov/cannabis/health-effects/cannabis-use-disorder.html [Link]